Q: Any idea why BMY tanked, down 11% Friday?
Thanks for your ongoing efforts toward your subscribers.
Mark
Thanks for your ongoing efforts toward your subscribers.
Mark
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: VBI Vaccines
Could you please give your opinion on this stock, and does it merit a buy at this price.
Could you please give your opinion on this stock, and does it merit a buy at this price.
Q: Any insights into this company and their expected success with their new anti-clotting drug?
Q: I read your summary back in December on MSL. It was not flattering. As you expected the stock continues to languish. Are there other Companies in this space you would prefer and would you sell MSL (small holding) to buy it?
Q: Hi Peter and Team,
I own this stock and am 20% under water, it continues going down but I could not find the reason. This stock looks cheap, the company have 17 m cash and no debt.
Pls give your thought on this company.
Should I continue to hold it?
Thank you for your professional advice.
Pui
I own this stock and am 20% under water, it continues going down but I could not find the reason. This stock looks cheap, the company have 17 m cash and no debt.
Pls give your thought on this company.
Should I continue to hold it?
Thank you for your professional advice.
Pui
Q: Would you give me your latest thoughts on TEVA
Q: MPH took a big dive today. Do you know why and is there some concern here? I am up over 100% so not too worried but would like some info.
Q: I have no exposure to healthcare but I would like to have some exposure. Can you recommend some investments to this sector and it does not have to be Canadian companies?
Q: Can you give me the updated short position on PLI please?
Joel
Joel
Q: I am underweight Healthcare, but do own RX - GILD - GUD - SIA. Both RX and GILD are down double digits. GILD I gather from previous questions is probably worth holding on to. But what about RX ...buy more, sell or hold? If sell, what would your "buy" suggestions be to beef up my healthcare weighting?
Thanks again.
Thanks again.
Q: chh. in 3-5 years do they have an ok chance of having stronger cash flow as they trim down their debt and possibly implementing a dividend. they look to be in a good growing sector, your in depth thoughts please.
Q: Hello Peter and gang.
I read your year end review and suggestions about investing in healthcare as a theme for 2017. I'm very much an income oriented investor. I'm interested in Medical Facilities Corp. Would you say this company falls under the category of healthcare? Also what's your overall view of this company.
Thanks
Nicholas
I read your year end review and suggestions about investing in healthcare as a theme for 2017. I'm very much an income oriented investor. I'm interested in Medical Facilities Corp. Would you say this company falls under the category of healthcare? Also what's your overall view of this company.
Thanks
Nicholas
Q: With mph providing a secured loan to apicore to replace knight(GUD)loan and taking on more debt what would be your thoughts on this move and would it be a buy sell or hold.
Q: On Dec 19th you specify Teva's debt at 6.5X cashflow and on Nov 10th you specify NET debt to cashflow at 1X. Is the difference in ratio's due to Teva's cash on hand? With Teva dropping 5% since the start of the year, would you buy now, wait, dollar cost average or stay away from the name?
Q: What is the best way to invest in US healthcare in a diversified portfolio seeing that they appear to be undervalued right now? Which ETFs/ stocks would you recommend?
Q: Hello Peter , Ryan, and 5i team,
We don't have any healthcare in our portfolios and I am thinking of adding some Knight Therapeutics to my TFSA. In sept 2015 , 5i rated GUD a B plus and mentioned that it is the best way to participate in a small cap growth company in healthcare. Do you still have the same view and what do you think of the current evaluation? I am also thinking of PLI in the small cap space or CSH.UN as a Reit/healthcare investment.
Thank you as always for your opinions.
We don't have any healthcare in our portfolios and I am thinking of adding some Knight Therapeutics to my TFSA. In sept 2015 , 5i rated GUD a B plus and mentioned that it is the best way to participate in a small cap growth company in healthcare. Do you still have the same view and what do you think of the current evaluation? I am also thinking of PLI in the small cap space or CSH.UN as a Reit/healthcare investment.
Thank you as always for your opinions.
Q: Gud was doing ok until Mackie downgraded it on Jan 4.I have a 0.50 position @ $10.Should I add now or after Jan20. CRH was recommended by a guest on BNN on Jan 6 basing on ROC of 104% & undervaluation.Please comment.Appreciate u usual great services & views
Q: Is PLI worth an investment at this time or should I stay away?
Q: Good morning,
I have half a position in Savaria and am looking to make this a full position. My question is regarding the outlook of growth in 2017. They have indicated that 60% of their business is in US. In this new protectionist environment in US, do you have any concerns here?
I have half a position in Savaria and am looking to make this a full position. My question is regarding the outlook of growth in 2017. They have indicated that 60% of their business is in US. In this new protectionist environment in US, do you have any concerns here?
Q: Peter and Team I have bought some PLI and I am currently down Apox.6% Is this Co. going any where or is it a sell.
Jim.
Jim.